Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design

This publication has 21 references indexed in Scilit:

• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
  The Lancet, 2000
• Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction
  Circulation, 1998
• ACE Inhibitors in Acute Myocardial Infarction
  Circulation, 1998
• Does Blockade of Angiotensin II Receptors Offer Clinical Benefits over Inhibition of Angiotensin–Converting Enzyme?
  Basic & Clinical Pharmacology & Toxicology, 1998
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992
• The Discovery of a New Class of Highly Specific Nonpeptide Angiotensin II Receptor Antagonists
  American Journal of Hypertension, 1991
• Angiotensin II-forming pathways in normal and failing human hearts.
  Circulation Research, 1990
• Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
  Circulation Research, 1985